The Endurance 1 Trial
Phase 4
Completed
- Conditions
- Diabetic Macular Edema
- Interventions
- Procedure: Focal Laser Treatment
- First Posted Date
- 2014-11-21
- Last Posted Date
- 2019-02-04
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Target Recruit Count
- 9
- Registration Number
- NCT02297204
Intravitreal Gas for Vitreomacular Adhesion
Not Applicable
Withdrawn
- Conditions
- Vitreomacular Adhesion
- Interventions
- Procedure: Intravitreal Injection of sulfahexafluoride gas
- First Posted Date
- 2013-12-05
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Registration Number
- NCT02001701
- Locations
- ๐บ๐ธ
Northern California Retina Vitreous Associates, Mountain View, California, United States
Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.
Phase 1
Completed
- Conditions
- Recalcitrant Wet Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2013-10-30
- Last Posted Date
- 2019-02-05
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Target Recruit Count
- 12
- Registration Number
- NCT01972763
- Locations
- ๐บ๐ธ
Northern California Retina Vitreous Associates, Mountain View, California, United States
NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions
Phase 4
Completed
- Conditions
- Macular Edema With Central Retinal Vein Occlusions
- Interventions
- First Posted Date
- 2013-06-06
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Target Recruit Count
- 20
- Registration Number
- NCT01870427
- Locations
- ๐บ๐ธ
Northern California Retina Vitreous Associates, Mountain View, California, United States
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
Phase 4
Completed
- Conditions
- UveitisMacular Edema
- Interventions
- First Posted Date
- 2013-06-06
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Target Recruit Count
- 10
- Registration Number
- NCT01870440
- Locations
- ๐บ๐ธ
Northern California Retina Vitreous Associates, Mountain View, California, United States
Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery
Phase 2
Completed
- Conditions
- Pseudophakic Cystoid Macular Edema,Diabetic Macular Edema
- Interventions
- First Posted Date
- 2011-01-27
- Last Posted Date
- 2012-10-04
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Target Recruit Count
- 6
- Registration Number
- NCT01284478
- Locations
- ๐บ๐ธ
Northern California Retina Vitreous Associates, Mountain View, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath